Cocrystal Pharma’s Upcoming Presentation at NobleCon 21
Bothell, WA - Cocrystal Pharma, Inc. (NASDAQ: COCP) is setting the stage for a significant presentation at the upcoming Noble Capital Markets 21st Emerging Growth Equity Conference. Scheduled for Wednesday, December 3, 2025, at 10:00 AM Eastern Time, the event will feature insights from James Martin, CFO and co-CEO of Cocrystal Pharma. His presentation will highlight the company's clinical progress and future directions at the Executive Education Complex of Florida Atlantic University.
Opportunity for Investors
Investors and interested parties are warmly invited to participate in this informative conference. Cocrystal Pharma offers a discounted registration rate, encouraging attendance for those keen to learn more about the company’s groundbreaking work in antiviral therapies. Prospective attendees can secure their spots using the discount code COCPNOBLECON.
What to Expect from the Presentation
During this presentation, attendees can anticipate a comprehensive overview of Cocrystal Pharma’s innovative approach to developing antiviral medications. The company focuses on unmet medical needs, utilizing unique structure-based technologies and tapping into Nobel Prize-winning scientific expertise. This approach aims to revolutionize treatments for viral diseases such as influenza, COVID-19, and hepatitis.
Live Webcast Availability
For those unable to attend in person, a video webcast will be accessible the day following the live presentation. This recording will be hosted on Cocrystal Pharma's official website and will remain available for 90 days, allowing broader access to their updates and insights.
About Noble Capital Markets
Noble Capital Markets is known for its dedication to supporting small and microcap enterprises. As a licensed broker-dealer, they provide essential services, including institutional-quality equity research, investment banking, and merchant banking services. Established in 1984, Noble recently launched Channelchek, a platform designed for public small and micro-cap companies, providing investors with free access to quality research.
Cocrystal Pharma's Mission and Vision
Cocrystal Pharma is committed to exploring innovative pathways to combat viral diseases. The company stands at the forefront of biotechnology, directing efforts toward answering pressing health challenges. Their pioneering work in developing antiviral drugs is framed by a focus on achieving first- and best-in-class therapies.
Contact Information
For further details, individuals can reach out to Alliance Advisors IR:
Jody Cain
Phone: 310-691-7100
Email: jcain@allianceadvisors.com
Frequently Asked Questions
What is the date and time of Cocrystal Pharma's presentation?
The presentation is scheduled for December 3, 2025, at 10:00 AM Eastern Time.
Where will the conference take place?
The event will be held at the Executive Education Complex of Florida Atlantic University.
How can I register for the conference?
Interested individuals can register using the discount code COCPNOBLECON for a reduced rate.
Will there be a recording of the presentation?
Yes, a video webcast will be available on the company's website one day after the presentation and will be archived for 90 days.
What focus areas does Cocrystal Pharma address?
Cocrystal Pharma develops antiviral treatments for several challenging diseases, including influenza, COVID-19, and hepatitis.
